InsidersTradesSigma
Follow the 와이바이오로직스 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 와이바이오로직스 has logged 29 insider filings. The latest transaction was reported on 9 July 2026 (Sale). Among the most active insiders: 장명자. Every trade is free.
24
Insider Decl.
n/a
Thresholds
€11,636
9 ops.
Buy Volume
n/a
7 ops.
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 July 2026
Declarations29 total
Other
Other
Other
Other
Other
25 of 29 declarations
About 와이바이오로직스
와이바이오로직스 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical products.